Here, the authors develop iPANDDA, a network-based computational pipeline that integrates multi-modal data to predict drug targets for SOX2-dependent lung squamous cell carcinoma, identifying and validating key targets like AKT and mTOR complexes. This evidence concerns the gene SOX2 and squamous cell lung carcinoma.